Showing 16 of 16 recruiting trials for “carcinoma-of-the-anal-canal”
Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
👨⚕️ Jeremie Calais, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Aug 2025View details ↗
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
👨⚕️ Anna S Wenning, MD, PhD, Department of Visceral Surgery and Medicine Inselspital, Bern University Hospital📍 7 sites📅 Started May 2025View details ↗
Ivonescimab in the Treatment of Multiple Advanced Tumors
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
👨⚕️ Gabriel A Brooks, M.D., Dartmouth-Hitchcock Medical Center📍 1 site📅 Started Jul 2023View details ↗
Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma
👨⚕️ Liu Guohua, Affiliated Hospital of Guangdong Medical University📍 1 site📅 Started Jul 2023View details ↗
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
👨⚕️ Moh'd Abu Hilal, MD, PhD, Fondazione Poliambulanza Instituto Ospedaliero📍 1 site📅 Started Jul 2023View details ↗
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
👨⚕️ Nadine Abi-Jaoudeh, MD, Chao Family Comprehensive Cancer Center📍 1 site📅 Started Sep 2022View details ↗
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
👨⚕️ Andrea B Apolo, Alliance for Clinical Trials in Oncology📍 580 sites📅 Started May 2019View details ↗
RecruitingNCT07199127 ↗
Duodenal Polyposis Classification in FAP
👨⚕️ Marco Vitellaro, M.D., Fondazione IRCCS Istituto Nazionale dei Tumori, Milano📍 2 sites📅 Started Feb 2018View details ↗
RecruitingNCT04104230 ↗
Quebec Pancreas Cancer Study
👨⚕️ George Zogopoulos, MD, PhD, McGill University Health Centre/Research Institute of the McGill University Health Centre📍 1 site📅 Started Mar 2012View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →